Severe Cholestasis and Bile Acid Nephropathy From Anabolic Steroids Successfully Treated With Plasmapheresis
- PMID: 26958570
- PMCID: PMC4748206
- DOI: 10.14309/crj.2016.24
Severe Cholestasis and Bile Acid Nephropathy From Anabolic Steroids Successfully Treated With Plasmapheresis
Abstract
Severe cholestasis with anabolic androgenic steroids is well-known to cause acute liver injury. Treatment is usually supportive after withdrawal of the offending agent. Acute kidney injury (AKI) frequently occurs in acute liver injury and may complicate management and prognosis. We highlight the use of plasmapheresis resulting in rapid improvement in cholestatic jaundice with resolution of AKI. Plasmapheresis should be considered in special cases in which there is progressive clinical decline despite supportive care.
Figures


References
-
- Seeff LB, Curto TM, Szabo G, et al. . Herbal product use by persons enrolled in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial. Hepatology. 2008;47(2):605–12. - PubMed
-
- LiverTox Web site. http://livertox.nih.gov. Accessed March 29, 2015.
-
- Parkinson AB, Evans NA. Anabolic androgenic steroids: A survey of 500 users. Med Sci Sports Exerc. 2006;38(4):644–51. - PubMed
-
- El Sherrif Y, Potts JR, Howard MR, et al. . Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: Contribution from ATP8B1/ABCB11 mutations? Liver Int. 2013;33(8):1266–70. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources